Cite

HARVARD Citation

    Beurskens, F. et al. (n.d.). C1q potentiates DR5 agonist activity by a mixture of two DR5-specific HexaBody® molecules. Molecular immunology. pp. 134-135. [Online]. 
  
Back to record